Previous 10 | Next 10 |
INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion Aggressive go-to-market sales, partnerships, and marketing strategy to bring INVOcell, fertility care that is accessible, inclusive, and affordable to the more than 90% of couples in ne...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The corporate earnings season slows down just a bit, but the conference and event schedule heats up with the Sohn Invest...
INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors Current Senior Advisor at McKinsey & Co. with strong expertise in global marketing and brand building PR Newswire SARASOTA, Fla. , April 26, 2021 /PRNewswire/ -- INVO Bio...
INVO Bioscience Joins in Supporting RESOLVE: The National Infertility Association During its National Infertility Awareness Week (NIAW) - RESOLVE is a non-profit action-based, infertility and family building organization who want to see increased access to all family building op...
INVO Bioscience (INVO) has executed a partnership agreement with Lyfe Medical focused on the expansion of the INVOcell solution in Northern California. Under terms of partnership agreement, Lyfe Medical will establish and operate a clinic in the San Francisco Bay Area to offer the INVO proced...
INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California - Approximately one in eight couples are affected by infertility in the United States PR Newswire SARASOTA, Fla. and SAN FRANCISCO , April 19, ...
INVO Bioscience to Present at Tribe Public Event on April 13, 2021 PR Newswire SARASOTA, Fla. , April 12, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO) , a medical device company focused on creating alternative treatments for patients diagnosed wi...
INVO Bioscience, Inc. (INVO) Q4 2020 Earnings Conference Call March 30, 2021 4:30 PM ET Company Participants Robert Blum – Investor Relations-Lytham Partners Steve Shum – Chief Executive Officer Mike Campbell – Chief Operating Officer and Vice President of Business Develo...
INVO BioScience (INVO): FY GAAP EPS of -$1.52 misses by $0.54.Revenue of $1.04M (-29.7% Y/Y) misses by $0.24M.As of December 31, 2020, the Company had a cash position of approximately $10.1 million.Shares -3.85%.Press Release For further details see: INVO BioScience EPS misses by $0.54,...
INVO Bioscience Reports 2020 Financial Results Company to Host Conference Call on March 30 at 4:30pm ET (Details Below) PR Newswire SARASOTA, Fla. , March 30, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on ...
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intrava...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
2024-04-18 06:37:00 ET Here’s the Top 3 Reasons to Trade Penny Stocks in 2024 Penny stocks represent a unique investment opportunity for those looking to diversify their portfolios with high-growth potential securities. Characterized by their low price per share, typically under ...